Basal lamina reduplication in malignant epithelioid pleural mesothelioma

Ultrastructural Pathology

Volumn 22, Issue 6, 1998, Pages 467-475

  Di Muzio, Marcello ^a   Spoletini, Luciana ^a   Strizzi, Luigi ^a   Procopio, Antonio ^a,e   Tassi, Gianfranco ^b   Casalini, Angelo ^c   Modesti, Andrea ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b Pneumology Section   (Italy)

^c Ospedale Rasori   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e Patologia Clinica   (Italy)

Author keywords

Adenocarcinoma; Basal lamina reduplication; Diagnosis; Mesothelioma

Indexed keywords

COLLAGEN TYPE 4;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALIGNANT TRANSFORMATION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0032416446     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129809032283     Document Type: Article

References (48)

1. 1. Leigh J, et al. The incidence of malignant mesothelioma in Australia: 1982-1988. Am J Ind Med. 1991;20:643-655.
2. 2. Zanetti R. Incidence of respiratory tract system tumors in Italy: data from the tumor registry. Ann 1st Sup Sanità. 1992;28:61-69.
3. 3. Chailleux E, Pioche D, Chopra S, et al. Epidemiology of malignant pleural mesothelioma in the Nantes-Saint Nazaire region: course in 1956-1992. Rev Mal Respir. 1995;12:353-357.
4. 4. Magnani C, Terracini B, Ivaldi C, Botta M, Mancini A, Andrion A. Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy. Occup Environ Med. 1995;52:362-367.
5. 5. Peto J, Hodgson JT, Matthwes FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345:535-539.
6. 6. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997;145:211-218.
7. 7. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994;9:1781-1790.
8. 8. Pepper C, Jasani B, Navabi H, Wynford-Thomas D, Gibbs AR. Simian-virus 40 large T antigen (SV40 Tag) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax. 1996;51:1074-1076.
9. 9. Naylor B. Pleural, peritoneal, and pericardial fluids. In: Bibbo M, ed. Comprehensive Cytopathology. Philadelphia: W.B. Saunders; 1997:551-621.
10. 10. Whitaker D, Sterrett G, Shilkin KB. Mesotheliomas. In: Gray W, ed. Diagnostic Cytopathology. New York: Churchill Livingstone; 1995:195-224.
11. 11. Bailey ME, Brown RW, Mody DR, Cagle P, Ramzy I. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic and mesothelial cells in serous effusion: comparison with carcinoembryonic antigen, B72.3 and Leu-M1. Acta Cytol. 1996:40:1212-1216.
12. 12. Jensen ML, Johansen P. Immunocytochemical staining of smears and corresponding cell blocks from serous effusion: a follow-up and comparative investigation. Diagn Cytopathol. 1996;15:33-36.
13. 13. Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract. 1996;192:137-147.
14. 14. Kuenen-Boumeester V, van-Loenen P, de-Bruijn EM, Henzen-Logmans SC. Quality control of immunocytochemical staining of effusions using a standardized method of cell processing. Acta Cytol. 1996;40:475-479.
15. 15. Eyden BP, Banik S, Harris M. Malignant epithelial mesothelioma of the peritoneum: observation on a problem case. Ultrastruct Pathol. 1996;20:337-344.
16. 16. Burns TR, Greenberg SD, Mace MC, Johnson EH. Ultrastructural diagnosis of ephithelial malignant mesothelioma. Cancer. 1985;56:2036-2040.
17. 17. Roggli VL, Sanfilippo F, Shelburne JD. Mesothelioma. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of Asbestos-Associated Diseases. Boston: Little, Brown; 1992:109-164.
18. 18. Ghadially FN. Ultrastructural Pathology of the Cell and Matrix. Boston: Butterworth-Heinmann; 1997.
19. 19. Cheville NF. Ultrastructural Pathology: An Introduction to Interpretation. Ames, IA: Iowa State University Press; 1994.
20. 20. Erlandson RA. Diagnostic Transmission Electron Microscopy of Tumors: With Clinicopathological, Immunohistochemical, and Cytogenetic Correlations. New York: Raven; 1994.
21. 21. Dardick I. Handbook of Diagnostic Electron Microscopy for Pathologists-in-Training. New York: Igaku-Shoin; 1996.
22. 22. Gould VE, Gould NS, Benditt EP. Basal lamina reduplication in human neoplasms. Am J Pathol. 1972;66:79A.
23. 23. Gould VE, Sommers SC, Trzakis JA. Squamous differentiation and basal lamina deposition in endometrial adenoacanthoma. Am J Pathol. 1976;84:25-38.
24. 24. Wellington J, Gould VE. Ultrastructure of anaplastic (spindle and giant cell) carcinoma of the thyroid. Cancer. 1975;35:1280-1292.
25. 25. Gould VE, Gould NS, Beneditt EP. Ultrastructural aspects of papillary and sclerosing carcinomas of the thyroid. Cancer. 1972;29:1613-1624.
26. 26. Gould VE, Miller J, Jao W. Ultrastructure of medullary, intraductal, tubular and adenoid cystic breast carcinomas. Am J Pathol. 1975;78:401-416.
27. 27. Jao W, Vazquez LT, Keh PC, Gould VE. Myoepithelial differentiation and basal lamina deposits in fibroadenoma and adenosis of the breast. J Pathol. 1978;126:107-112.
28. 28. Thrasher TV, Richart RM. An ultrastructural comparison of endometrial adenocarcinoma and normal endometrium. Cancer. 1972;29:1713-1723.
29. 29. Tandler B. Ultrastructure of adenoid cystic carcinoma of salivary gland origin. Lab Invest. 1984;51:82-87.
30. 30. Warhol MJ, Hickey WF, Corson JM. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Am J Surg Pathol. 1982;6:307-314.
31. 31. Rusch VN, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1996;111:815-825.
32. 32. Pass HI, Kranda K, Temeck BK, Feuerstein I, Steinberg SM. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997;4:215-222.
33. 33. Beauchamp HD, et al. The role of closed needle biopsy in the diagnosis of malignant mesothelioma of the pleura. Chest. 1992;102:1110-1112.
34. 34. Roussel F, Nouvet G. Evaluation of large-needle biopsy for the diagnosis of cancer. Acta Cytol. 1995;38:449-452.
35. 35. Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul P, Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients, I: diagnosis. Cancer. 1993;72:389-393.
36. 36. Boutin C, Loddenkemper R, Astoul P. Diagnostic and therapeutic thoracoscopy: techniques and indications in pulmonary medicine. Tuber Lung Dis. 1993;74:225-239.
37. 37. Sugarbaker DJ, Garcia JP, Richards WP, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg. 1996;224:288-294.
38. 38. Weatherford DA, Stephensen JE, Taylor SM, Blackhurst D. Thoracoscopy versus thoracotomy: indications and advantages. Ann Surg. 1995;61:83-86.
39. 39. Ghadially FN, Rippstein PV, Cavell S, Venance SL. Giant desmosomes in tumors. Ultrastruct Pathol. 1995;19:469-474.
40. 40. Pääkkö P, Risteli J, Risteli L, Autio-Harmainen H. Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes. Am J Surg Pathol. 1990;14:464-473.
41. 41. Sukoh N, Nakajima I, Ogura S, Isobe H, Inoue K, Kawakami Y. Immunohistochemical distribution of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virchows Arch. 1994;424:33-38.
42. 42. Kwon TJ, Ro JY, Tornos C, Ordonez NG. Reduplicated basal lamina in clear-cell carcinoma of the ovary: an immunohistochemical and electron microscopic study. Ultrastruct Pathol. 1996;20:529-536.
43. 43. Chan YF, Choi AC, Ma L, Leung MP. Infantile hemangioendothelioma of the liver: ultrastructural study of a type II case. Pathology. 1986;18:463-468.
44. 44. Suster S, Amazon K, Rosen LB, Ollague JM. Malignant epithelioid schwannoma of the skin: a low grade neurotropic malignant melanoma? Am J Dermatopathol. 1989;11:338-344.
45. 45. Hewan-Lowe K, Dardick I. Ultrastructural distinction of basaloid-squamous carcinoma and adenoid cystic carcinoma. Ultrastruct Pathol. 1995;19:371-381.
46. 46. Klominek J, Robert KH, Sundqvist KG. Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen and an autocrine motility factor-like substance. Cancer Res. 1993;53:4376-4382.
47. 47. Vracko R, Benditt EP. Basal lamina: the scaffold of orderly cell replacement. J Cell Biol. 1972;55:406-419.
48. 48. Vracko R, Benditt EP. Capillary basal lamina thickening: its relation to cell death and replacement. J Cell Biol. 1970;47:281-285.